View Cart (0)
View Wishlist (0)
Checkout
1-800-586-6038
Premade Lentivirus → Cas9 lentivirus → eSpCas9 lentivirus (CAG, Neo)

eSpCas9 lentivirus (CAG, Neo)

eSpCas9 (enhanced specificity Cas9) has enhanced specificity compared to wild type Cas9 for CRISPR/Cas9 genome editing. eSpCas9 is able to reduce off-target effects and maintain robust on-target genome editing efficiency, allowing more efficient gene targeting. eSpCas9 (CAG, Neo) lentivirus expresses eSpCas9 under the control of the CAG promoter with neomycin as a selection marker, allowing selecting stable cell clones with neomycin.

 

Virus: eSpCas9 lentivirus (CAG, Neo)
Titer (approx): 1 x 107 TU/ml
Vector Information: Vector includes both 5’ and 3’ lentiviral LTR and all necessary elements for effective transduction; woodchuck hepatitis virus posttranscriptional regulatory element (WPRE)
Promoter for Target Gene: CAG
Target Gene / Reporter(s): eSpCas9
Selection Gene: neomycin
Biosafety Level: BSL-2
Shipped: Dry ice
Storage: Store at -80°C


User Instructions | Plasmid Map | Materials Safety Data Sheet

Catalog Number Product Size Price Qty
PLV-10189-50
eSpCas9 lentivirus (CAG, Neo)(2 x 25 µl)
 Titer 1x10^7 TU/ml
Price: $298.00
PLV-10189-200
eSpCas9 lentivirus (CAG, Neo) (8x25ul)
 Titer 1x10^7 TU/ml
Price: $595.00
  • Payment Methods
 
Copyright | 2025 Cellomics Technology, LLC. All Rights Reserved. | 1450 South Rolling Rd., Halethorpe, MD 21227 | 1.800.586.6038
Loading...